查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853914

产后出血治疗器材市场（依器械类型、应用、最终用户和分销管道划分）－全球预测，2025-2032年

Postpartum Hemorrhage Treatment Devices Market by Device Type, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，产后出血治疗设备市场规模将达到 14.232 亿美元，复合年增长率为 6.48%。

关键市场统计数据
基准年 2024 8.6094亿美元
预计年份：2025年 9.1691亿美元
预测年份 2032 14.232亿美元
复合年增长率 (%) 6.48%

本书全面介绍了影响产后出血装置创新和应用的动态因素、临床需求和结构性因素。

产后出血仍然是全球最紧急的产科急症之一，而器械辅助治疗已成为临床医生套件中的重要工具。近年来，临床实践强调快速识别、标准化流程以及策略性地部署能够支援止血并同时维护产妇尊严和生育能力的器械。在此背景下，製造商加快了产品研发週期并完善了监管申报流程，医疗系统也重新评估了采购重点，以优先选择具有明确临床价值和运作稳定性的器材。

本节从一般观察着手，逐步过渡到实务层面，将产后急救设备置于更广泛的孕产妇健康创新背景下进行探讨。文章讨论了影响需求的临床因素，包括某些地区剖腹产率的上升、不断变化的产程管理实践以及对品质指标日益增长的重视。此外，文章还重点阐述了设备性能特征、在高压环境下的易用性以及与现有临床工作流程的兼容性之间的相互关係。最后，引言概述了影响相关人员如何优先考虑预防和治疗方式投资的结构性因素——政策、供应链和支付方动态——为后续章节奠定了基础。

临床实务的转变、监管政策的明确化和技术的融合如何重塑产后出血的器械研发和治疗模式

产后出血治疗器材领域正经历一场变革，从临床实践到监管规范的明确性以及技术的融合。临床医生越来越倾向于选择兼具简单性和强效止血性能的解决方案，这推动了子宫球囊填塞术和新型快速床边止血剂的发展。同时，电外科平台和缝合系统的进步弥补了二次出血处理中一些特定的操作缺陷，而弹性绷带系统则在转运和固定过程中提供了额外的机械支撑。

除了产品层面的创新，医疗服务模式也正在改变。床边决策支援、基于模拟的培训以及能够缩短干预时间的综合护理路径正在医院和门诊环境中整合。监管机构正在明确迭代式设备改进和真实世界证据产生的路径，加速渐进式创新产品的市场准入，并促进上市后监测合作。总而言之，这些发展正在建立一个更模组化和互通的生态系统，在这个系统中，製造商、医疗服务提供者和支付者必须在整个孕产妇保健过程中合作，才能实现更好的治疗效果。

评估2025年美国关税对设备采购、生产布局和采购韧性的营运和供应链影响

美国关税将于2025年生效，由此引入的贸易政策层面为设备製造商和医疗服务提供者的供应链架构和筹资策略带来了新的考量。短期内，依赖跨国零件采购的公司面临不断上涨的到岸成本，迫使它们重新考虑供应商多元化、安全库存策略和近岸外包方案，以保持价格竞争力。这些商业应对措施也促使供应商重新审视其合约框架，并寻求更长期的协议，以确保关键设备的稳定供应。

除了直接的成本压力外，关税也在影响企业在製造地和监管协调方面的策略决策。一些公司加快了对国内製造和本地组装的投资，以减轻关税的影响；而另一些公司则优先考虑设计变更，以减少对受关税影响的原材料的依赖。因此，采购团队越来越关注产品的全生命週期，包括设备耐用性、消毒流程以及对影响营运连续性的耗材的依赖程度。展望未来，累积政策讯号强调供应链的韧性和适应性，促使企业重新关注供应商品质、双源采购策略以及根据关税波动快速调整物流的能力。

基于精细细分的洞察，包括设备类型、临床用途、终端用户行为和通路，定义了采用动态和采购选项。

透过细緻的细分视角，我们可以发现不同器械类别、应用、最终用户和通路在器械的采纳率、临床效用和商业策略方面存在差异。按器械类型划分，弹性绷带系统（包括腹部加压绷带和骨盆固定带）因其能够即时提供机械稳定性，且易于在院前和院间转运中使用而备受青睐；电外科器械分为双极和单极两种平台，有助于控製手术出血。止血剂种类繁多，从胶原蛋白和明胶基製剂到粉状和海绵状製剂，应有尽有。缝合系统包括用于快速子宫修復的预製缝合器械和用于最终手术治疗的标准缝合套件。子宫球囊填塞解决方案，无论是现成的填塞球囊或低成本的避孕套式填塞装置，都能为资源不同的环境提供扩充性的选择。

预防和治疗在应用层面的差异会影响临床医师选择设备和製定诊疗路径的方式。预防策略优先考虑能够降低严重出血发生率的设备和通讯协定，而治疗策略则强调出血发生后快速有效地控制出血。具备全面外科手术能力和血库支援的医院倾向于整合更完善的电外科和缝合系统，而诊所和门诊手术中心则优先考虑便携、易于培训且耗材依赖性低的设备。销售管道进一步影响产品的市场进入和市场推广。直销关係能够提供捆绑式培训和服务合同，在线销售扩大了标准化产品的覆盖范围，而第三方经销商有助于在物流和法规环境复杂的地区获得产品。总而言之，这种市场细分揭示了临床需求、营运能力和商业策略的交汇点，从而影响产品优先顺序和采购行为。

美洲、欧洲、中东和非洲以及亚太地区的区域动态如何影响产后出血治疗设备的取得、报销和临床应用

区域动态对医疗器材的可及性、报销和临床实践模式有着显着影响，每个宏观区域都为相关人员带来了独特的机会和挑战。在美洲，许多医疗系统先进的基础设施支持了更复杂医疗器材的快速普及，但由于支付方组成、医院认证要求以及农村地区就医难等问题，仍然存在显着的异质性。一些市场的报销机制和基于价值的倡议奖励了那些能够显着降低併发症发生率和缩短住院时间的干预措施，从而推动了对可整合到标准化止血方案中的医疗器械的投资。

在欧洲、中东和非洲，监管环境健全的国家与资源匮乏的国家之间有显着差异。资源匮乏地区对低成本、易于部署的解决方案（例如避孕套式卫生棉条和携带式压迫系统）的需求日益增长。亚太地区则呈现出基础设施快速发展、法规环境多样化以及日益重视在地化生产和技术转移的动态组合。官民合作关係和政府主导的采购计画加速了该地区的规模化发展，而文化和培训因素则影响着医疗器材的选择和临床培训策略。在所有地区，相关人员必须适应当地的实务规范、监管要求和物流实际情况，以确保医疗设备能够送达最需要的地方，并发挥其最大作用。

竞争与策略洞察揭示了创新、伙伴关係和证据生成如何塑造差异化和成长机会。

产后出血医疗器材领域的竞争动态体现了渐进式创新、策略伙伴关係以及扩大临床应用途径之间的平衡。大型企业正投资于临床证据的累积、上市后註册研究以及旨在加快第一线临床医生胜任能力提升的培训计画。同时，新兴企业则专注于细分市场解决方案，例如低成本的填塞物和新型止血配方，以满足资源匮乏地区尚未满足的需求。医疗设备公司与学术中心或医疗系统之间的伙伴关係日益增多，这正推动着真实世界临床试验的开展，从而增强产品的价值提案并支持医保报销。

如今，产品差异化已不再局限于效能指标，还涵盖供应链稳定性、模组化服务产品和综合培训方案。能够展现出持续的品管、精简的灭菌和一次性使用方案以及可扩展的培训模式的公司，将获得采购团队的支持。此外，积极与监管机构沟通，建立清晰的证据路径，并建立在地化生产和分销能力的公司，可以降低复杂地区的准入门槛。总而言之，这些策略措施将影响企业的竞争定位，并决定哪些企业最有能力推广能够显着降低产后出血相关发生率的解决方案。

为製造商、医疗保健提供者和经销商提供具有高影响力的策略建议，以加速产品应用、改善治疗效果并增强供应链韧性。

产业领导者可以采取有针对性的措施，在管控营运和政策风险的同时，加速产品推广应用并改善临床疗效。製造商应优先考虑情境化设计方法，使产品功能与预期的临床实际情况相符，并确保设备在人员配备、消毒方法和供给能力的限制下正常运作。同时，投资于可扩展的培训计画、基于模拟的课程和数位化支援工具，可以减少推广应用的障碍，并增强临床医生使用预防性和治疗性干预措施的信心。从商业性角度来看，建立结合直销、电子商务和经销商合作的灵活分销模式，可以优化覆盖不同终端使用者类型和地理范围。

采购和临床负责人应采用总使用成本框架来评估医疗器械方案，除了考虑单位成本外，还应将耗材、培训、消毒和物流纳入考虑。他们还应参与合作合同，例如基于绩效的供应协议和批量采购安排，以使製造商的奖励与临床结果保持一致。最后，相关人员应采取积极主动的供应链弹性措施，例如双源采购策略和紧急库存计划，以减轻政策变化和关税相关中断的影响。实施这些建议将有助于使商业性奖励与临床优先事项保持一致，并提高产后出血干预措施的永续性。

调查方法，结合主要相关人员参与、证据综合和迭代检验，为分析提供支持。

本分析采用混合研究途径，整合了主要相关人员参与、有针对性的文献回顾和严谨的证据三角验证。一级资讯来源包括与临床医生、采购专业人员、监管专家和供应链经理进行的结构化访谈和定性讨论，以了解各环境下的营运实际情况和未满足的需求。我们将这些相关人员的意见与检验侪审查的临床研究、监管申报文件、器械标籤资讯和公开的政策文件系统地结合起来，从而为临床和商业性洞察建立了可靠的依证。

分析方法包括对质性研究结果进行主题综合分析、对设备属性和应用案例进行比较评估，以及基于情境的供应链和政策影响评估。为确保假设和解释与实际经验相符，我们与外部临床顾问和行业专家进行了反覆的回馈检验。为确保透明度，我们详细记录了资料来源类型、整合标准以及资料可用性方面的任何固有限制。这种严谨的调查方法为报告中提出的趋势、细分洞察和策略建议提供了可靠的解读依据。

整合关键见解和前瞻性要务，协调临床创新、供应链韧性和协作行动，以降低产后出血的发生率

降低产后出血的发生率需要医疗设备、诊疗路径和供应链设计的协同进步。临床创新正在推动快速部署、简化培训和提升实际疗效，这些优先事项正在再形成产品开发和采购决策。政策和贸易动态增加了新的复杂性，迫使相关人员优先考虑供应链韧性和适应性筹资策略，以确保不间断地获得救生设备。

最终，最具影响力的干预措施将出现在临床证据、产品设计和商业性执行与当地医疗服务实际情况相契合的领域。那些投资于严谨的证据收集、客製化培训和灵活分销的相关人员，将更有利于推广能够改善治疗效果的解决方案。展望未来，连接製造商、临床医生、医疗系统和政策制定者的跨部门合作，对于将设备层面的改善转化为产后出血相关併发症的持续降低至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在资源匮乏的医疗机构中增加子宫内球囊填塞系统的使用
  • 推广使用可生物降解的止血海绵来控制产后出血
  • 扩大可携式超音波设备在产后早期检测子宫收缩乏力中的应用
  • 人工智慧驱动的风险评估平台出现，用于预测产后出血併发症
  • 利用微导管创新技术扩展子宫动脉栓塞装置，实现更安全的介入治疗
  • 医疗设备製造商与非政府组织合作，向服务不足地区分发产后出血套件
  • 用于快速子宫压迫和缝合的微创手术器械的普及
  • 用于治疗产后出血的药物输送和机械压迫联合系统的监管核准
  • 开发一种穿戴式失血监测感测器，用于持续追踪产后出血情况
  • 人们对基于三维成像和患者解剖结构的客製化子宫填塞球囊的兴趣日益浓厚

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依设备类型分類的产后出血治疗设备市场

  • 弹性绷带系统
    • 腹部加压绷带
    • 骨盆束缚器
  • 电外科设备
    • 双极元件
    • 单极装置
  • 止血剂
    • 胶原蛋白类药物
    • 明胶类药物
    • 粉末
    • 海绵
  • 缝合系统
    • 预製缝合器械
    • 标准缝合套件
  • 子宫球囊填塞术
    • 市售的填塞气球
    • 保险套填塞

9. 按应用分類的产后出血治疗设备市场

  • 预防
  • 治疗

第十章 依最终使用者分類的产后出血治疗设备市场

  • 门诊手术中心
  • 诊所
  • 医院

第十一章 依分销管道分類的产后出血治疗器械市场

  • 直销
  • 线上销售
  • 第三方经销商

第十二章 各地区产后出血治疗器材市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 产后出血治疗器材市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国产后出血治疗器材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Cook Incorporated
    • Teleflex Incorporated
    • Becton, Dickinson and Company
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Merit Medical Systems, Inc.
    • Smiths Group plc
    • Johnson & Johnson Services, Inc.
    • Boston Scientific Corporation
    • ConMed Corporation
Product Code: MRR-DD5AD9F59CCA

The Postpartum Hemorrhage Treatment Devices Market is projected to grow by USD 1,423.20 million at a CAGR of 6.48% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 860.94 million
Estimated Year [2025] USD 916.91 million
Forecast Year [2032] USD 1,423.20 million
CAGR (%) 6.48%

A definitive introduction to postpartum hemorrhage device dynamics, clinical imperatives, and the structural forces shaping innovation and adoption

Postpartum hemorrhage remains one of the most urgent obstetric emergencies worldwide, and device-based interventions have emerged as critical tools in the clinician toolkit. In recent years, clinical practice has emphasized rapid recognition, standardized protocols, and the strategic deployment of devices that support hemostasis while preserving maternal dignity and fertility. Against this backdrop, manufacturers have accelerated product development cycles, regulatory submissions have grown more sophisticated, and health systems have re-evaluated procurement priorities to emphasize devices that deliver clear clinical value and operational resilience.

Moving from general observation to actionable perspective, this section situates postpartum hemorrhage treatment devices within the broader landscape of maternal health innovation. It describes the clinical drivers-such as rising cesarean rates in some regions, evolving labor management practices, and heightened emphasis on quality metrics-that shape demand. It also highlights the interplay between device performance characteristics, ease of use in high-stress scenarios, and compatibility with existing clinical workflows. Finally, the introduction frames the subsequent sections by outlining the structural forces-policy, supply chains, and payer dynamics-that will influence how stakeholders prioritize investments in prevention and treatment modalities.

How converging clinical practice shifts, regulatory clarity, and technology convergence are reshaping postpartum hemorrhage device development and care delivery

The landscape for postpartum hemorrhage devices is undergoing transformative shifts across clinical practice, regulatory pathways, and technology convergence. Clinicians increasingly favor solutions that combine simplicity with robust hemostatic performance, which has catalyzed interest in uterine balloon tamponade options and newer hemostatic agents that can be deployed rapidly at the bedside. Simultaneously, advances in electrosurgical platforms and suturing systems are addressing specific procedural gaps in secondary hemorrhage management, while elastic bandage systems provide adjunctive mechanical support during transport or stabilization.

Beyond product-level innovation, care delivery models are shifting. Hospitals and ambulatory settings alike are integrating point-of-care decision support, simulation-based training, and bundled care pathways that improve time-to-intervention. Regulatory authorities are clarifying pathways for iterative device improvements and real-world evidence generation, which accelerates market entry for incremental innovations and encourages post-market surveillance partnerships. Taken together, these developments are producing a more modular and interoperable ecosystem in which manufacturers, providers, and payers must coordinate across the continuum of maternal care to realize improvements in outcomes.

Assessing the operational and supply chain repercussions of United States tariffs in 2025 on device sourcing, manufacturing footprint, and procurement resilience

The layer of trade policy introduced by United States tariffs enacted in 2025 has introduced new considerations for supply chain architecture and procurement strategies across device manufacturers and healthcare providers. In the immediate term, firms reliant on cross-border component sourcing have confronted higher landed costs and have had to revisit supplier diversification, safety stock strategies, and nearshoring options to preserve price competitiveness. These operational responses have also prompted providers to re-examine contracting frameworks and to seek longer-term agreements to stabilize access to critical devices.

In addition to direct cost pressures, tariffs have influenced strategic decision-making around manufacturing footprint and regulatory alignment. Some firms have accelerated investments in domestic manufacturing or local assembly to mitigate tariff exposure, while others have prioritized design changes that reduce dependence on tariff-exposed inputs. As a result, procurement teams are increasingly focused on total lifecycle considerations, including device durability, sterilization pathways, and consumable dependencies that affect operational continuity. Looking forward, the cumulative policy signal has emphasized resilience and adaptability in supply chains, driving a renewed focus on supplier quality, dual-sourcing strategies, and the ability to reconfigure logistics rapidly in response to tariff volatility.

Granular segmentation-driven insights into device types, clinical applications, end-user behaviors, and distribution pathways that define adoption dynamics and procurement choices

A nuanced segmentation lens reveals how adoption, clinical utility, and commercial strategies diverge across device categories, applications, end users, and distribution pathways. Within the landscape of device types, elastic bandage systems-encompassing abdominal compression wrapping and pelvic binders-are valued for immediate mechanical stabilization and ease of use in pre-hospital and interfacility transfers, whereas electrosurgical devices, split across bipolar and monopolar platforms, serve in definitive surgical control of bleeding. Hemostatic agents present a broad portfolio that ranges from collagen-based and gelatin-based agents to powders and sponges, each with distinct handling characteristics and suitability for different bleeding etiologies. Suturing systems include prefabricated suturing devices for rapid uterine repair and standard suturing kits for definitive surgical management, and uterine balloon tamponade solutions, whether commercial tamponade balloons or low-cost condom tamponade constructs, offer scaled options for resource-variable settings.

Application-level distinctions between prevention and treatment shape how clinicians select devices and structure care pathways. Preventative strategies prioritize devices and protocols that reduce the incidence of severe hemorrhage, and treatment-oriented use focuses on rapid, effective control once bleeding occurs. End users also create divergent adoption patterns; hospitals with comprehensive surgical capacity and blood bank support will tend to integrate a broader range of electrosurgical and suturing systems, while clinics and ambulatory surgery centers emphasize portability, ease of training, and devices that minimize consumable dependencies. Distribution channels further modulate market access and adoption; direct sales relationships enable bundled training and service agreements, online sales expand reach for standardized products, and third-party distributors facilitate access in regions with complex logistics or regulatory environments. Taken together, segmentation illuminates where clinical need, operational capacity, and commercial strategy intersect to shape product prioritization and procurement behavior.

How regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific shape access, reimbursement, and clinical adoption of postpartum hemorrhage devices

Regional dynamics exert strong influence on device availability, reimbursement, and clinical practice patterns, and each macro-region presents distinct opportunities and constraints for stakeholders. In the Americas, advanced infrastructure in many health systems supports rapid adoption of higher-complexity devices, yet there remains significant heterogeneity driven by payer mix, hospital accreditation requirements, and rural access challenges. Reimbursement mechanisms and value-based initiatives in select markets incentivize interventions that demonstrably reduce complication rates and length of stay, which in turn encourages investment in devices that can be integrated into standardized hemorrhage bundles.

In Europe, Middle East & Africa, the landscape varies considerably between countries with robust regulatory frameworks and those with constrained resources. In higher-resource settings, stringent clinical evaluation and procurement committees demand evidence of comparative effectiveness and cost-efficiency, whereas in resource-limited contexts there is heightened demand for low-cost, highly deployable solutions such as condom tamponade constructs and portable compression systems. Asia-Pacific presents a dynamic mix of rapid infrastructure development, diverse regulatory environments, and an increasing emphasis on local manufacturing and technology transfer. Here, public-private partnerships and government-led procurement programs can accelerate scale-up, while cultural and training considerations influence device selection and clinical training strategies. Across all regions, stakeholders must adapt to local practice norms, regulatory expectations, and logistical realities to ensure devices reach the points of care where they will have the greatest impact.

Competitive and strategic company insights revealing how innovation, partnerships, and evidence-generation shape differentiation and scaling opportunities

Competitive dynamics among companies active in postpartum hemorrhage devices reflect a balance between incremental innovation, strategic partnerships, and pathways to broaden clinical adoption. Leaders are investing in clinical evidence generation, post-market registries, and training programs that reduce time-to-competency for frontline clinicians. At the same time, emerging companies focus on niche solutions-such as low-cost tamponade options or novel hemostatic formulations-that address unmet needs in resource-constrained environments. Partnerships between medical device firms and academic centers or health systems increasingly facilitate real-world studies that strengthen value propositions and support reimbursement discussions.

Product differentiation now extends beyond performance metrics to include supply chain stability, modular service offerings, and integrated training packages. Firms that can demonstrate consistent quality control, streamlined sterilization or single-use options, and scalable training models gain traction with procurement teams. Moreover, companies that proactively engage with regulatory bodies to establish clear evidence pathways and that build localized manufacturing or distribution arrangements can reduce barriers to entry in complex geographies. Collectively, these strategic behaviors influence competitive positioning and determine which organizations are best placed to scale solutions that materially reduce morbidity related to postpartum hemorrhage.

High-impact strategic recommendations for manufacturers, providers, and distributors to accelerate adoption, improve outcomes, and strengthen supply chain resilience

Industry leaders can take targeted actions to accelerate adoption and improve clinical outcomes while managing operational and policy risks. Manufacturers should prioritize design-for-context approaches that align product features with the realities of intended clinical settings, ensuring that devices perform reliably within the constraints of staffing, sterilization practices, and supply availability. Concurrently, investing in scalable training programs, simulation-based curricula, and digital support tools will reduce barriers to adoption and enhance clinician confidence in using both prevention- and treatment-oriented interventions. From a commercial perspective, establishing flexible distribution models that combine direct sales, e-commerce availability, and distributor partnerships can optimize reach across diverse end-user types and geographies.

Procurement and clinical leaders should adopt total-cost-of-use frameworks when evaluating device options, accounting for consumables, training, sterilization, and logistics in addition to unit price. They should also engage in collaborative contracting that aligns manufacturer incentives with clinical outcomes, such as performance-based supply agreements or bundled purchasing arrangements. Finally, stakeholders should pursue proactive supply chain resilience measures, including dual-sourcing strategies and contingency inventory planning, to mitigate the effects of policy shifts and tariff-related disruptions. Implementing these recommendations will help align commercial incentives with clinical priorities and improve the sustainability of postpartum hemorrhage interventions.

Transparent and robust mixed-method research methodology combining primary stakeholder engagement, evidence synthesis, and iterative validation to underpin the analysis

The analysis is grounded in a mixed-methods research approach that integrates primary stakeholder engagement, targeted literature synthesis, and rigorous evidence triangulation. Primary data sources included structured interviews and qualitative consultations with clinicians, procurement specialists, regulatory experts, and supply chain managers to capture operational realities and unmet needs across settings. This stakeholder input was systematically combined with peer-reviewed clinical research, regulatory filings, device labeling information, and publicly available policy documents to establish a robust evidence base for clinical and commercial insights.

Analytical techniques included thematic synthesis of qualitative findings, comparative evaluation of device attributes and use cases, and scenario-based assessment of supply chain and policy impacts. Validation occurred through iterative feedback loops with external clinical advisors and industry experts to ensure that assumptions and interpretations aligned with frontline experience. Transparency measures included detailed documentation of source types, synthesis criteria, and any limitations inherent in data availability. This methodological rigor supports confident interpretation of the trends, segmentation insights, and strategic recommendations presented throughout the report.

Synthesis of pivotal insights and forward-looking imperatives to align clinical innovation, supply chain resilience, and collaborative action in reducing postpartum hemorrhage morbidity

The collective analysis underscores a clear imperative: reducing morbidity from postpartum hemorrhage will require coordinated advances across devices, care pathways, and supply chain design. Clinical innovation is progressing in ways that prioritize rapid deployability, ease of training, and real-world effectiveness, and these priorities are reshaping product development and procurement decisions. Policy and trade dynamics have added a new layer of complexity, compelling stakeholders to prioritize supply chain resilience and adaptive sourcing strategies in order to maintain uninterrupted access to life-saving devices.

Ultimately, the most impactful interventions will arise where clinical evidence, product design, and commercial execution align with local care delivery realities. Stakeholders that invest in rigorous evidence generation, tailored training, and flexible distribution will be best positioned to scale solutions that improve outcomes. Moving forward, cross-sector collaboration-bridging manufacturers, clinicians, health systems, and policymakers-will be essential to translate device-level improvements into sustained reductions in postpartum hemorrhage-related morbidity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing utilization of intrauterine balloon tamponade systems in low-resource healthcare settings
  • 5.2. Accelerated introduction of biodegradable hemostatic sponges for postpartum bleeding control
  • 5.3. Increasing integration of portable ultrasound devices for early detection of uterine atony postpartum
  • 5.4. Emergence of AI-driven risk assessment platforms to predict postpartum hemorrhage complications
  • 5.5. Expansion of uterine artery embolization devices with microcatheter innovations for safer intervention
  • 5.6. Collaborations between device manufacturers and NGOs to distribute PPH kits in underserved regions
  • 5.7. Surge in minimally invasive surgical instruments designed for rapid uterine compression and suturing
  • 5.8. Regulatory approvals of combination drug delivery and mechanical tamponade systems for PPH management
  • 5.9. Development of wearable blood loss monitoring sensors for continuous postpartum hemorrhage tracking
  • 5.10. Growing focus on custom-fit uterine tamponade balloons based on 3D imaging and patient anatomy data

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Postpartum Hemorrhage Treatment Devices Market, by Device Type

  • 8.1. Elastic Bandage Systems
    • 8.1.1. Abdominal Compression Wrapping
    • 8.1.2. Pelvic Binders
  • 8.2. Electrosurgical Devices
    • 8.2.1. Bipolar Devices
    • 8.2.2. Monopolar Devices
  • 8.3. Hemostatic Agents
    • 8.3.1. Collagen Based Agents
    • 8.3.2. Gelatin Based Agents
    • 8.3.3. Powders
    • 8.3.4. Sponges
  • 8.4. Suturing Systems
    • 8.4.1. Prefabricated Suturing Devices
    • 8.4.2. Standard Suturing Kits
  • 8.5. Uterine Balloon Tamponade
    • 8.5.1. Commercial Tamponade Balloon
    • 8.5.2. Condom Tamponade

9. Postpartum Hemorrhage Treatment Devices Market, by Application

  • 9.1. Prevention
  • 9.2. Treatment

10. Postpartum Hemorrhage Treatment Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Postpartum Hemorrhage Treatment Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Sales
  • 11.3. Third Party Distributors

12. Postpartum Hemorrhage Treatment Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Postpartum Hemorrhage Treatment Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Postpartum Hemorrhage Treatment Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Cook Incorporated
    • 15.3.2. Teleflex Incorporated
    • 15.3.3. Becton, Dickinson and Company
    • 15.3.4. Baxter International Inc.
    • 15.3.5. B. Braun Melsungen AG
    • 15.3.6. Merit Medical Systems, Inc.
    • 15.3.7. Smiths Group plc
    • 15.3.8. Johnson & Johnson Services, Inc.
    • 15.3.9. Boston Scientific Corporation
    • 15.3.10. ConMed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY